Banner

Soluble Fms-Like Tyrosin Kinase-1 and Placental Growth Factor Biomarkers Integrated for Predictability of Preeclampsia

• 2023
Back
Publication Information
Authors Mahmoud Abosrea*, Ahmed Mousad* and Asmaa Elfallah
Keywords Not Available
Journal Not Available
Publisher Not Available
Volume Not Available
Issue Not Available
Pages Not Available
publication.type Local
Paper Link Not Available
Supplementary Materials Not Available
Abstract
Background: Biomarkers in diagnostic and prognostic approaches in obstetric research efforts are gaining a global interest however the sensitivity and specificity of those biomarkers are considered an issue of research debate
Aim: To investigate usefulness and reliability of implementing the usage of sFlt-1/PIGF ratio for predictability of the presence or absence of preeclampsia development.
Methodology: A cohort and randomized research study was conducted on 50 pregnant cases, the course of pregnancy was observed extensively in randomly selected pregnant women. Personal and history data, personal habits, the course and pregnancy clinical outcome was recorded. Research study subjects were equally categorized in two groups as follows: the control group and the preeclampsia group. Serum levels of sFlt-1 and PIGF in obtained samples was determined retrospectively by usage of Elecsys assays on an electrochemiluminescence immunoassay platform and implemented to calculate the sFlt-1/PIGF ratio.
Result: Comparative statistical analysis of soluble fms-like tyrosine kinase 1, placental growth factor and sFLT/PlGF ratio among term and preterm preeclampsia cases showed highly statistical significant difference between term and preterm research categories of preeclampsia cases as regards soluble fms-like tyrosine kinase 1 (pg/ml) 24-28 GA, 28-31 GA (p values